Browse by author
Lookup NU author(s): Dr Gurdeep SagooORCiD, Dr Nawaraj BhattaraiORCiD, Professor David Deehan
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
© 2025 Sagoo et al. Aims: The aim of this study was to estimate the additional cost per quality-adjusted life-year (QALY) of robotic-assisted total knee arthroplasty (rTKA) compared to manually performed total knee arthroplasty (mTKA). Methods An economic evaluation was undertaken from the UK NHS and personal social services perspective, alongside a randomized controlled trial comparing rTKA and mTKA. Costs were estimated individually using a top-down approach and included all healthcare resources incurred during the trial. Costs were presented in 2021 GBP sterling (£). Responses to the EuroQol five-dimension three-level questionnaire were used to estimate QALYs for each participant. The incremental cost-effectiveness ratio (ICER) was evaluated against the current willingness-to-pay threshold recommended by the National Institute for Health and Care Excellence. Stochastic sensitivity analysis was performed using bootstrapping techniques, and results were shown through the cost-effectiveness acceptability curve and cost-effec-tiveness plane. Cost-effectiveness over one-and ten-year time horizons were explored using a decision model. Results There were 100 participants randomized: 50 rTKA and 50 mTKA. Overall, 37 participants (39.4%) had some missing data on either costs or utilities, or on both. Multiple imputation was used for the base case results. The intervention was associated with incremental mean per-patient costs of £1,829 (95% CI 421 to 3,238) and an incremental QALY gain of 0.015 (95% CI-0.05 to 0.0796) at one year. The ICER at one year was £123,770. However, rTKA was likely to be cost-effective over a ten-year time horizon, with an ICER of £11,109. All except one of the scenarios (QALY gain reduction to 0.005) explored supported the cost-effectiveness of rTKA over a ten-year time horizon with an ICER below a £20,000 threshold. Conclusion Over a short one-year time horizon, rTKA was not a cost-effective procedure compared to mTKA. However, when results were extrapolated out to a ten-year time horizon, which would need to be confirmed in future research, rTKA was likely to be cost-effective.
Author(s): Sagoo GS, Clement ND, Gil-Rojas Y, Bhattarai N, Galloway S, Baron JB, Smith K, Weir DJ, Deehan DJ
Publication type: Article
Publication status: Published
Journal: Bone and Joint Open
Year: 2025
Volume: 6
Issue: 6
Pages: 658-666
Online publication date: 07/06/2025
Acceptance date: 02/04/2018
Date deposited: 30/06/2025
ISSN (electronic): 2633-1462
Publisher: British Editorial Society of Bone and Joint Surgery
URL: https://doi.org/10.1302/2633-1462.66.BJO-2024-0274
DOI: 10.1302/2633-1462.66.BJO-2024-0274
Data Access Statement: The data that support the findings for this study are available to other researchers from the corresponding author upon reasonable request.
Altmetrics provided by Altmetric
